NIH StrokeNet Clinical Trials and Biomarker Studies for Stroke Treatment, Recovery, and Prevention (UG3/UH3 Clinical Trial Optional) (351647)

From US Department of Health & Human Services: National Institutes of Health (NIH)

The National Institutes of Health (NIH), a part of the U.S. Department of Health and Human Services, is the nation’s medical research agency — making important discoveries that improve health and save lives.

Type of Support

Overview

This grant program is designed to support multi-site exploratory and confirmatory clinical trials related to stroke, including interventions, biomarker or outcome measure validation studies that are preparatory for trials in stroke prevention, treatment, and recovery, as well as ancillary studies adding scientific aims to active studies within StrokeNet. The program aims to facilitate collaboration within the NIH StrokeNet, where the National Coordinating Center (NCC) and National Data Management Center (NDMC) will provide implementation, statistical, and data management support. The Regional Coordinating Centers (RCCs) along with their affiliated clinical sites will assist with recruitment, retention, and on-site implementation of clinical protocols.

Eligibility

Organization's Location
USA, American Samoa, Guam, Northern Mariana Islands, Puerto Rico, British Virgin Islands
Program Location
USA, American Samoa, Guam, Northern Mariana Islands, Puerto Rico, Virgin Islands
Organization Type
not specified

Submission

Visit Apply for more information.